REDDING, Calif., May 9, 2024 /PRNewswire/ -- According to a new
market research report titled, 'Spatial Genomics Market by Type
(Genomics, Transcriptomics) Technology (Sequencing, Imaging)
Application (Oncology, Neurology) Offering (Consumables,
Instrument, Software) End User (Pharmaceutical & Biotechnology,
CRO)—Global Forecast to 2031.', published by Meticulous
Research®, the spatial genomics & transcriptomics
market is projected to reach $3.23
billion by 2031 at a CAGR of 27.8% from 2024 to 2031.
Download Sample Report-
https://www.meticulousresearch.com/download-sample-report/cp_id=5763
Spatial genomics involves exploring genomics (comprising total
DNA and RNA), transcriptomics (RNA transcripts), and epigenomics
(molecular compounds) profiling methods to acquire information
within a spatial context conducted within intact tissue. This
approach aids in establishing a molecular link between genotypes
and phenotypes. The significance of spatial genomics arises from
the intricate three-dimensional structure of the human body, which
plays a crucial role in our molecular physiology. To gain a
comprehensive understanding of genomics, studying it in a spatial
context becomes essential. Consequently, there is a growing demand
for spatial techniques in genomics research.
The growth of the spatial genomics & transcriptomics market
is driven by the increasing applications of spatial genomics in
drug discovery & development, the growing use of spatial
genomics in cancer research, advancements in Next-generation
Sequencing (NGS), the increasing use of spatial genomics in
biomarker detection, and the rising prevalence of cancer. However,
the lack of standardized approaches in genomics and concerns over
the security & privacy of genomic data restrain the growth of
this market.
Furthermore, the rising adoption of personalized medicines and
gene therapies and increasing investments in spatial genomics are
expected to generate growth opportunities for the players operating
in this market. However, complexities in data analysis and slow
technology adoption are major challenges impacting market
growth.
Rising Adoption of Personalized Medicines Generating Growth
Opportunities for Market Players
Personalized/precision medicine uses an individual's genomic
information to offer targeted treatments. Spatial genomics is used
for the genetic profiling of tumors to identify targetable
mutations and gain insights into intercellular communication and
the visualization of microanatomical structures in tumors, which
drives the utilization of the technology in precision medicine.
Spatial genomics approaches are used to identify changes in gene
expression, genetic variations, or epigenetic modifications
associated with a particular disease or condition, which makes it
useful in the development of personalized medicines.
Additionally, spatial genomics can help identify potential
biomarkers and signaling pathways to enable diagnosis, prognosis
evaluation, targeted therapies, early detection, and noninvasive
monitoring. Spatial transcriptomics is an important aspect of
personalized medicine as it provides a cell or tissue-specific
spatial context for extending, interpreting, and understanding the
information captured from multiple biomarkers, which is important
in guiding treatment decisions in personalized medicine.
Get a Glimpse Inside: Request Sample Pages-
https://www.meticulousresearch.com/request-sample-report/cp_id=5763
In the case of rare genetic disorders, personalized medicine
approaches help identify specific genetic mutations causing a
condition and enable the designing of therapies to correct or
mitigate their effects. The key players in this market are
partnering to develop advanced solutions to aid the development of
precision therapeutics. For instance, in January 2023, Akoya Biosciences (U.S.) partnered
with Agilent Technologies, Inc. (U.S.) to develop chromogenic and
immunofluorescent multiplex assays that include spatial analysis
for biopharma companies advancing precision cancer
therapeutics.
The key players operating in the spatial genomics &
transcriptomics market are NanoString Technologies, Inc. (U.S.),
10X Genomics, Inc. (U.S.), Illumina, Inc. (U.S.), Oxford Nanopore
Technologies Plc. (U.K.), Akoya Biosciences, Inc. (U.S.), Revvity,
Inc. (U.S.), S2 Genomics, Inc. (U.S.), Cantata Bio (U.S.), Vizgen
Inc. (U.S.), Biospyder Technologies Inc. (U.S.), and Resolve
Biosciences GmbH (Germany).
The global spatial genomics market is segmented by offering,
type, technology, application, and end user. The study also
evaluates industry competitors and analyzes their market share at
global and regional levels.
Among all offerings studied in this report, in 2024, the
instruments segment is expected to account for the largest share of
56% of the spatial genomics market. However, the instruments
segment is expected to grow at the highest CAGR during the forecast
period. Technological advancements in instruments have led to full
automation, high-throughput analyses, and inbuilt software
interfaces for easy operation. Additionally, key players are
introducing advanced instruments to fulfill researchers'
requirements, supporting market growth. For instance, in
January 2022, Akoya Biosciences, Inc.
(U.S.) launched the PhenoCycler-Fusion instrument, which offers a
high-throughput workflow at sub-cellular resolution for 100+
markers (either RNA or protein biomarkers).
Among all types studied in this report, in 2024,
the transcriptomics segment is expected to account for the
largest share of 82% of the spatial genomics market.
Increasing use of spatial transcriptomics by end users as it
provides insights about biological interactions at the cellular
level to gain insights into complex tissues, such as tumor
microenvironments. Additionally, the market players are launching
new products in spatial transcriptomics, supporting the segment's
market growth. For instance, in February
2023, Curio Bioscience (U.S.) launched a Curio Seeker, the
high-resolution mapping kit for whole transcriptomics. Curio Seeker
enables laboratories to generate whole-transcriptome spatial data
from tissue samples in an easy-to-use workflow.
Have Specific Research Needs? Request a Customized
Report-
https://www.meticulousresearch.com/request-customization/cp_id=5763
Among all technologies studied in this report, the
sequencing-based segment is expected to grow at the highest CAGR of
31% during the forecast period. Declining costs of genome
sequencing, technological advancements in sequencing, increasing
pharmaceutical R&D expenditure, and the surge in genome mapping
programs are driving the market growth. Additionally, NGS-based
spatial transcriptomics approaches ensure high throughput compared
to imaging-based methodologies as the entire transcript information
is detected and massively parallel-processed, driving the market
growth.
Among all applications studied in this report, the oncology
segment is expected to grow at the highest CAGR during the forecast
period. The increasing use of spatial transcriptomics products for
oncology research, increasing prevalence of cancer, and growing
focus on cancer research are driving the market growth.
Additionally, researchers are using spatial genomics platforms to
identify oncology biomarkers and gain information on oncology
biomarkers for the development of cancer treatment is driving the
market.
Among all end users studied in this report, in 2024, the
pharmaceutical and biotechnology companies segment is expected to
account for the largest share of 58% of the spatial genomics
& transcriptomics market. The largest share of this segment is
attributed to the increasing demand for new drugs and therapies,
leading to extensive research and development activities, rising
funding and investments in the pharmaceutical and biotech industry,
and increasing healthcare expenditure. Furthermore, the
pharmaceutical and biotechnology industries constantly strive to
develop new drugs and therapies to address medical needs, further
driving market growth.
Geographically, in 2024, North
America is expected to account for the largest share of
46% of the spatial genomics market. The North America spatial genomics market is
estimated to be worth USD 267.5
million in 2024. The region's large share is attributed
to the high R&D expenditure, high prevalence of chronic
diseases, growth in the pharmaceuticals industry, and large number
of research laboratories. Additionally, projects like The Cancer
Genome Atlas (TCGA) have been conducted in the region, leading to
the development of targeted therapies and personalized treatment
approaches leading to the largest share of the region.
The report also includes an extensive assessment of the key
strategic developments of leading market participants in the
industry over the past years (2020–2023). In the last couple of
years, the global spatial genomics & transcriptomics market
witnessed several strategic developments.
Browse the In-depth Report-
https://www.meticulousresearch.com/product/spatial-genomics-market-5763
Scope of the Report:
Spatial Genomics Market Assessment, by Offering
- Instruments
- Consumables
- Software & Services
Spatial Genomics Market Assessment, by Type
Spatial Genomics Market Assessment, by Technology
- Imaging Based
- Sequencing Based
Spatial Genomics Market Assessment, by
Application
- Oncology
- Neurology
- Other Applications
Note: Other applications consist of infectious diseases and
immunology.
Spatial Genomics Market Assessment, by End User
- Pharmaceutical & Biotechnology Companies
- Contract Research Organizations
- Other End Users
Note: Other end users include academic institutes
& research centers and agriculture companies.
Spatial Genomics Market Assessment, by Geography
- North America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Rest of Europe (RoE)
- Asia-Pacific (APAC)
- China
- Japan
- India
- Rest of Asia-Pacific
(RoAPAC)
- Latin America
- Middle East & Africa
Unlock Opportunities: Buy Now-
https://www.meticulousresearch.com/Checkout/82840788
Related Reports:
Genomics Market by Offering (Systems, Consumables,
Software, Services), Technology (Sequencing, Microarray, PCR),
Application (Diagnostics, Life Science Research), End User
(Pharmaceutical Companies, Hospitals, Academic Institutes, CRO) -
Global Forecast to 2030
Molecular Diagnostics Market by Product (Reagent
& Kits, Systems, Software), Test Type (Lab, PoC), Technology
(PCR, ISH, INAAT, Sequencing, Microarray), Application (Infectious
Diseases, Oncology), End User (Hospital, Diagnostic Lab) – Global
Forecast to 2030
Next Generation Sequencing (NGS) Market by
Offering (Kits [Library Prep, QC, DNA Extraction], System) Type
(Genome, Exome, Targeted) Application (Reproductive, Oncology,
Infectious) Technology (SBS, Nanopore, Nanoball, SMRT Seq) – Global
Forecast to 2030
Related Blogs:
Spatial Genomics & Transcriptomics: The Emerging
Molecular Profiling Method
Top 10 Companies in Spatial Genomics Market
About Meticulous Research®
Meticulous Research® was founded in 2010 and incorporated as
Meticulous Market Research Pvt. Ltd. in 2013 as a private limited
company under the Companies Act, 1956. Since its incorporation, the
company has become the leading provider of premium market
intelligence in North America,
Europe, Asia-Pacific, Latin
America, and the Middle
East & Africa.
The name of our company defines our services, strengths, and
values. Since the inception, we have only thrived to research,
analyze, and present the critical market data with great attention
to details. With the meticulous primary and secondary research
techniques, we have built strong capabilities in data collection,
interpretation, and analysis of data including qualitative and
quantitative research with the finest team of analysts. We design
our meticulously analyzed intelligent and value-driven syndicate
market research reports, custom studies, quick turnaround research,
and consulting solutions to address business challenges of
sustainable growth.
Contact:
Mr. Khushal
Bombe
Meticulous Market Research Inc.
1267 Willis St, Ste 200 Redding,
California, 96001, U.S.
USA: +1-646-781-8004
Europe : +44-203-868-8738
APAC: +91 744-7780008
Email- sales@meticulousresearch.com
Visit Our Website: https://www.meticulousresearch.com/
Connect with us on LinkedIn-
https://www.linkedin.com/company/meticulous-research
Content Source:
https://www.meticulousresearch.com/pressrelease/998/spatial-genomics-market-2031
Logo:
https://mma.prnewswire.com/media/1757980/Meticulous_Research_Logo_1.jpg
View original
content:https://www.prnewswire.co.uk/news-releases/spatial-genomics-market-to-be-worth-3-23-billion-by-2031---exclusive-report-by-meticulous-research-302141139.html